ZS Pharma Corporate Statement
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/31/2026
- Wall Street ends lower after Fed Chair Warsh reaffirms inflation fight
- Fed chair Warsh kicks off Jackson Hole keynote address
- PayPal tumbles as Advent, Stripe said to drop $50 bln pursuit
- Oil settles lower on clues about Fed policy, rumors of Hormuz deal
- Dollar jumps after Warsh comments, set for weekly gain
- McKesson reports cybersecurity incident affecting its information systems
- Mizuho is bullish on Broadcom ahead of Sept. 2 earnings, citing 30-quarter streak
- Wall Street ends lower after Fed Chair Warsh reaffirms inflation fight
- BioNTech ends colorectal cancer mRNA therapy trial early
- Needham sees mature node semiconductor strength in latest tracker
ZS Pharma's (ZSPH) Price Target Raised to $83 at BMO
September 11, 2015 8:22 AM EDTBMO Capital maintained an Outperform rating on ZS Pharma (NASDAQ: ZSPH) and raised its price target to $83.00 (from $70.00).
For an analyst ratings summary and ratings history on ZS Pharma click here. For more ratings news on ZS Pharma click here.
Shares of ZS Pharma closed at $74.73 yesterday.
... MoreZS Pharma's (ZSPH) Price Target Raised to $110 at William Blair
September 11, 2015 8:21 AM EDTWilliam Blair maintained an Outperform rating on ZS Pharma (NASDAQ: ZSPH) and raised its price target to $110.00 (from $75.00).
For an analyst ratings summary and ratings history on ZS Pharma click here. For more ratings news on ZS Pharma click here.
Shares of ZS Pharma closed at $74.73 yesterday.
... MoreZS Pharma (ZSPH) to Resume Trading at 5:50 PM
September 10, 2015 5:36 PM EDTZS Pharma (NASDAQ: ZSPH) to Resume Trading at 5:50 PM
... More